---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-25-000075"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T03:01:31.521415+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Labcorp Q2 revenue $3.53B, Adj EPS $4.35; raises full-year guidance

## Summary
- Q2 revenue $3.53B (+9.5% YoY); diluted EPS $2.84 vs $2.43; adjusted EPS $4.35 vs $3.94.
- Full-year guidance raised: revenue growth 7.5%-8.6%; adjusted EPS $16.05-$16.50; FCF $1.13-$1.28B.
- Diagnostics Labs revenue $2.75B (+8.9%); Biopharma Lab Services $784.8M (+11.0%).
- Quarterly dividend $0.72/share declared; $200M stock repurchased in Q2.
- Announced acquisitions of select assets from Incyte Diagnostics, BioReference Health, and Community Health Systems.

## SEC filing metadata
- accession: 0000920148-25-000075
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014825000075/0000920148-25-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014825000075/lh-20250724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-25-000075
- JSON: https://secwatch.observer/filing/0000920148-25-000075.json
- Plain text: https://secwatch.observer/filing/0000920148-25-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.